APA

Calabria S., Cinconze E., Rossini M., Rossi E., Maggioni A. P., Pedrini A. & De Rosa M. (20160504). Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. : Patient preference and adherence.

Chicago

Calabria S, Cinconze E, Rossini M, Rossi E, Maggioni A P, Pedrini A and De Rosa M. 20160504. Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. : Patient preference and adherence.

Harvard

Calabria S., Cinconze E., Rossini M., Rossi E., Maggioni A. P., Pedrini A. and De Rosa M. (20160504). Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. : Patient preference and adherence.

MLA

Calabria S, Cinconze E, Rossini M, Rossi E, Maggioni A P, Pedrini A and De Rosa M. Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis. : Patient preference and adherence. 20160504.